Nobody screens you for disordered eating before prescribing a GLP-1. That is not an accident. It is a gap in the entire informed consent process, and it is the subject of this conversation.
I talk with Dr. Michelle Tubman, an emergency physician, about what informed consent for GLP-1 medications should actually include and rarely does.
In this episode you will learn:
What Michelle sees in the emergency room after patients start GLP-1 medications
Why most people never connect their symptoms back to the medication
What the two-year Ozempic study actually found about weight regain
Why disordered eating screening is not required before a GLP-1 prescription
What true informed consent would require, modeled on how oncologists handle chemotherapy
Podden och tillhörande omslagsbild på den här sidan tillhör
Stephanie Dodier. Innehållet i podden är skapat av Stephanie Dodier och inte av,
eller tillsammans med, Poddtoppen.